The team, led by Stanford's Paul Mischel, is now looking at ways to block the anchor proteins that help ecDNA do its job, potentially opening up new ways to fight tough cancers.
But experts like Lillian Siu remind us there is still more to learn, since other factors like unstable genomes also make cancer tricky to treat.